检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《中国癌症防治杂志》2009年第2期153-154,共2页CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
摘 要:目的观察评价三维适形放射治疗技术(3-DCRT)治疗原发及继发性肝癌的治疗疗效。方法1998年11月至2007年12月对55例原发及继发性肝癌患者进行3-DCRT治疗,总剂量D_T45~60Gy/15~30F,3~6w,正常肝组织V_(30)<33%。结果55例患者中,CR 6例(10.9%),PR 26例(47.3%),NC 15例(27.3%),PD 8例(14.5%),总有效率(CR+PR)58.2%。1、2、3年生存率分别为67.3%(37/55)、34.9%(15/43)、23.3%(7/30)。结论3-DCRT治疗肝癌安全有效,毒副反应小。Objective To evaluate the treatment effect of 3-dimentional con-formal radiotherapy (3-DCRT) on the patients with primary or secondary liver cancer. Method 55 patients with primary or secondary liver cancer from November 1998 to December 2007 were treated with 3-DCRT. The total doses were DT45-60Gy/15-30F/3-6w,and the V30 of normal liver tissue was 〈 33%. Results of 55 patients, there were 6 ( 10. 9% ) patients with CR, 26 (47.3%) with PR, 15 (27.3%) with NC and 8 ( 14. 5% ) with PD. The total effective rate (CR + PR) was 58.2%. The one-,two- and three-year survival rates were 67. 3% (37/55), 34. 9% (15/43) and 23.3% (7/30) ,respectively. Conclusions 3-DCRT is effective and safe for the patients with liver cancer, and its side effect is slight.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.54